Skip to main content

Your search for “Pharmacology” returned 282 results

Cancer and the Goldilocks Effect

April 3, 2014

Researchers at the University of California, San Diego School of Medicine have found that too little or too much of an enzyme called SRPK1 promotes cancer by disrupting a regulatory event critical for many fundamental cellular processes, including proliferation.

Why Omega-3 Oils Help at the Cellular Level

May 15, 2012

For the first time, researchers at the University of California, San Diego have peered inside a living mouse cell and mapped the processes that power the celebrated health benefits of omega-3 fatty acids. More profoundly, they say their findings suggest it may be possible to manipulate these processes to short-circuit…

UC San Diego Superfund Research Program Receives $15 Million Grant Renewal

May 22, 2012

The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, has renewed funding for the Superfund Research Program (SRP) at the University of California, San Diego. Over the next five years, the $15 million grant will fund continued research on the molecular and genetic consequences…

UC San Diego’s Tsien Honored with First-Ever “Golden Goose Award”

September 13, 2012

…Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego School of Medicine who shared the 2008 Nobel Prize in chemistry for his role in helping develop and expand the use of green fluorescent proteins (GFP) was honored today with one of the first-ever “Golden…

UC San Diego Secures Several Top Spots in Latest National Rankings for NIH Funding

April 11, 2024

University of California San Diego solidified its status as a national leader in National Institutes of Health (NIH) funding, as reported by the 2023 Blue Ridge Institute for Medical Research (BRIMR) rankings.

State Stem Cell Agency Funds Three New UC San Diego Projects

August 25, 2021

The California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to UC San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis.

Stand Up To Cancer Grant Funds UC San Diego Health Research in Pancreatic Cancer

November 20, 2018

A team of University of California San Diego School of Medicine researchers have been awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.

Researchers Identify Liver Cancer Progenitor Cells Before Tumors Become Visible

October 10, 2013

Researchers at the University of California, San Diego School of Medicine have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma tumors – the most common form of liver cancer. The researchers found ways to identify and isolate the HCC progenitor cells long before actual…

Enzyme Drives Cognitive Decline in Mice, Provides New Target for Alzheimer’s

November 28, 2022

UC San Diego researchers identify the PKCα enzyme as a promising therapeutic target in Alzheimer’s disease; a mutation that increases its activity led to biochemical, cellular and cognitive impairments in mice.

$1.5 Million Donation Supports Research on Effects of Psychedelic DMT on the Brain

July 11, 2023

UC San Diego Psychedelics and Health Research Initiative received the gift from philanthropist Eugene Jhong to further our understanding of the unique states of consciousness induced by DMT and how it could benefit human health.

Category navigation with Social links